Rescue Stenting
0
Pipeline Programs
1
Companies
1
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
1 companies ranked by most advanced pipeline stage
AcandisGermany - Pforzheim
1 programRescue stenting with CREDO heal Stent together with NeuroSpeed PTA Balloon CatheterN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2023
2024
2025
2026
2027
AcandisRescue stenting with CREDO heal Stent together with NeuroSpeed PTA Balloon Catheter
Clinical Trials (1)
Total enrollment: 153 patients across 1 trials
NCT05345483AcandisRescue stenting with CREDO heal Stent together with NeuroSpeed PTA Balloon Catheter
REscue Stenting With CREDO® Heal for Recanalisation After Unsuccessful Thrombectomy (RECHRUT)
Start: Jan 2023Est. completion: Jan 2027153 patients
N/ARecruiting
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 153 patients
1 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.